Back
Context Therapeutics, Inc. Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Buy
74
CNTX
Context Therapeutics, Inc.
Last Price:
$2.46
Seasonality Move:
-0.89%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Context Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.86 | Buy |
| 20-day SMA: | 1.67 | Buy |
| 50-day SMA: | 1.34 | Buy |
| 200-day SMA: | 0.98 | Buy |
| 8-day EMA: | 1.97 | Buy |
| 20-day EMA: | 1.7 | Buy |
| 50-day EMA: | 1.44 | Buy |
| 200-day EMA: | 1.16 | Buy |
Context Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 83.17 | Buy |
| Chaikin Money Flow: | 2798804 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.26 - 1.88) | Buy |
| Bollinger Bands (100): | (0.93 - 1.51) | Buy |
Context Therapeutics, Inc. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Context Therapeutics, Inc. Stock
Is Context Therapeutics, Inc. Stock a Buy?
-
Context Therapeutics, Inc. share price is 2.40 while CNTX 8-day simple moving average is 1.86, which is a Buy signal.
-
The stock price of CNTX is 2.40 while Context Therapeutics, Inc. 20-day SMA is 1.67, which makes it a Buy.
-
Context Therapeutics, Inc. 50-day simple moving average is 1.34 while CNTX share price is 2.40, making it a Buy technically.
-
CNTX stock price is 2.40 and Context Therapeutics, Inc. 200-day simple moving average is 0.98, creating a Buy signal.
CNTX Technical Analysis vs Fundamental Analysis
Buy
74
Context Therapeutics, Inc. (CNTX)
is a Buy
Is Context Therapeutics, Inc. a Buy or a Sell?
-
Context Therapeutics, Inc. stock is rated a BuyThe current Context Therapeutics, Inc. [CNTX] share price is $2.40. The Score for CNTX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
Context Therapeutics, Inc. Stock Info
Market Cap:
225.6M
Price in USD:
2.40
Share Volume:
4M
Context Therapeutics, Inc. 52-Week Range
52-Week High:
2.45
52-Week Low:
0.49
Buy
74
Context Therapeutics, Inc. (CNTX)
is a Buy
Context Therapeutics, Inc. Share Price Forecast
-
What is the Context Therapeutics, Inc. stock price today?The Context Therapeutics, Inc. stock price is 2.40 USD today.
-
Will CNTX stock go up or go down?Context Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Context Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Context Therapeutics, Inc. is not overvalued.
Is Context Therapeutics, Inc. Stock a Buy?
-
Context Therapeutics, Inc. share price is 2.40 while CNTX 8-day exponential moving average is 1.97, which is a Buy signal.
-
The stock price of CNTX is 2.40 while Context Therapeutics, Inc. 20-day EMA is 1.70, which makes it a Buy.
-
Context Therapeutics, Inc. 50-day exponential moving average is 1.44 while CNTX share price is 2.40, making it a Buy technically.
-
CNTX stock price is 2.40 and Context Therapeutics, Inc. 200-day simple moving average is 1.16, creating a Buy signal.
Fundamental Analysis of Context Therapeutics, Inc.
Is Context Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $0.01 per share.
Technical Analysis of Context Therapeutics, Inc.
Should I short Context Therapeutics, Inc. stock?
-
CNTX Moving Average Covergence Divergence (MACD) indicator is 0.22, suggesting Context Therapeutics, Inc. is a Buy
-
Context Therapeutics, Inc. Relative Strength Index (RSI) is 83.17, which suggest Context Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Context Therapeutics, Inc. is (1.26 - 1.88), which suggest Context Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Context Therapeutics, Inc. is (0.93 - 1.51), which suggest Context Therapeutics, Inc. is a Buy
* Context Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.